Defibrotide Plus Best Standard of Care vs Best Standard of Care Alone to Prevent Sinusoidal Obstruction Syndrome After HSCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial
Lancet Haematol 2023 Mar 28;[EPub Ahead of Print], SA Grupp, S Corbacioglu, HJ Kang, T Teshima, SL Khaw, F Locatelli, J Maertens, M Stelljes, P Stepensky, P Lopez, V Amber, A Pagliuca, PG Richardson, M MohtyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.